ClinicalTrials.gg
RecruitingNCT07549373Updated Nov 19, 2026

Effect of Diode Laser, Gudmar and Vinegar in Diabetic Patients During Root Canal Treatment

An interventional study of 940 nm diode laser and apple cider vinegar in Diabete Type 2, sponsored by Sharda University. Recruiting at 1 site in India. Open to participants aged 25 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Sharda University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started May 2026; still recruiting 6 months later.
Updated Nov 19, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
25 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 403 studies in Diabetes Mellitus, Type 2 with a site in India — 33 open to participants now, 38 under way, 18 of them phase 3. Diabetes Mellitus, Type 2 · India.

Planned enrollment
298th of 342
90 · median 463
Started
2026
with 21 others
No phase
43 of 403
8 open now
Primary completion
2026-08
later than 10 of 37 live
Registered
384th of 403
by date

Among the 403 studies in Diabetes Mellitus, Type 2 with a site in India, this one is the 298th largest by planned enrollment of the 342 interventional ones that give a count, is one of 22 that started in 2026, is one of 43 with no phase, reaches primary completion later than 10 of the 37 other live ones, and was the 384th registered.

Diabetes Mellitus, Type 2

10,403 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,413 are open to participants now.

Browse Diabetes Mellitus, Type 2 studies →

Open to participants now

33 of the 403 studies in Diabetes Mellitus, Type 2 with a site in India are open now. Recruiting first, the newest first:

27 more — sign in →

All 33 open studies →

A study can be open while its sites in India have not opened yet or have stopped. Only those recruiting at a site in India →

Who these studies take

Of the 882 Diabetes Mellitus, Type 2 studies recruiting now, 372 (42%) set no upper age limit and 384 (44%) stop at 75 or younger; 52 take children under 18; 202 take healthy volunteers.

This study: 25 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 403 studies in Diabetes Mellitus, Type 2 with a site in India, or all of them as a file.
02

Study summary

Methodology

Patient with diabetes 2 with informed consent -convenience sampling over a one year period.The tooth isolated with a rubber dam and the correct disinfection procedures will be used. researcher will do the Access preparation Working length -electronic apex locator (Dentsply Propex II) as well as a radiographic approach.

After the canals will be obturated using ZOE sealer and gutta percha and post endodontic restoration is done using composite restoration. Patient is kept on follow up for 7days, 15 days, 30 days ,45 days and 60 days Clinical outcome is measure using periapical radiograph (RVG) Pain is measured using visual analog scale to mark the pain intensity. Data will be analysed statistically To enlarge the root canals (ISO size 20 file)

A sterile paper point inside the root canal for one minute until the apex of the root canal is reached

Using T.E Buffer, samples will be delivered to the School Of Basic Life Sciences, Sharda University.

The samples will be subjected to traditional PCR analysis for the detection of Peptostreptococcus spp. in the root canal.

Grouping Following instrumentation, 5% NaOCl and 17% EDTA irrigation will be done. Control group (n=15) The final irrigant will be saline Group 1 (n=15) Irrigation using 5% apple cider vinegar done The final irrigant will be saline Group 2 (n=15) Diode laser is used for disinfection in the presence of saline Group 3 (n=15) Gymnema Sylvestre Mother Tincture Q 1000 CH solution is used for disinfection in the presence of saline Group 4 (n=15) Diode laser is used for disinfection in the presence of 5% apple cider vinegar. The final irrigant will be saline Group 5 (n=15) Diode laser is used for disinfection in the presence of Gymnema Sylvestre Mother Tincture Q 1000 CH solution. The final irrigant will be saline

After cleaning and shaping, samples will be collected and sent through T.E. Buffer to the School Of Basic Life Sciences, Sharda University.

The samples will be subjected to traditional PCR analysis for the detection of Peptostreptococcus spp. in the root canal.

Read the detailed description

Study design and ethical consideration The present study will be a randomized controlled clinical study conducted over the period of one year; the study protocol will be reviewed and approved by the institutional; ethics committee , sharda university. All procedures will be performed in accordance with the ethical standards laid down in the declaration of Helsinki.

Patients diagnosed with type 2 diabetes mellitus will be recruited after obtaining written informed consent. Convenience sampling will be employed due to the clinical nature of the study and availability of eligible patient reporting to the out patient department during the study period. .Randomisation will be done using lottery method Patient selection and sampling method Type 2 diabetic patients fulfilling the inclusion criteria will be selected using a convenience sampling technique over a one year period.

Convenience sampling has been widely used in clinical endodontic trials where strict criteria limit patient availability.

After patient recruitment, the selected tooth will be isolated using the rubber dam to maintain asepsis and prevent salivary contamination, which is critical for accurate microbiological sampling.

Access cavity preparation will be performed using and access opening bur # 2 followed by refinement of the access wall using an endo z carbide bur to ensure straight line access to root canals.

Working length determination The working length was determined using the electronic apex locator (Dentsply propex II) and radiographic verification. The use of an electronic apex locator in conjunction with a radiograph has been shown to improve accuracy and reduce procedural errors.

Canal instrumentation and initial microbiological sampling Root canal enlargement was performed up ISO size 20 file , following standardized instrumentation protocol to ensure uniformity across all groups For predisinfection microbial sampling , a sterile paper point was inserted into the root canal and maintained for 1 min, ensuring it reached the apical 3rd of the canal. This technique has been validated for effective recovery of intracanal microorganisms.

The collected paper points were immediately transferred into strile vials containing TE buffer, which preserve bacterial DNA integrity during transport.

Transport and microbiological analysis All sample were transported to the school of basics life sciences , under sterile conditions The samples were subjected to PCR analysis for the detection of peptostreptococcus species, which are obligate anaerobics commonly associated with persistent endodontic infections and apical periodontitis.

PCR was chosen due to its high sensitivity and specificity in detecting low bacterial loads compared to culture methods

Grouping and Disinfection Protocol Following biochemical preparations, all canals were irrigated using 5% sodium hypochlorite (NaOCI) and 17% EDTA, which are considered the gold standard for organic tissues dissolution and smear layer removal, respectively

Patients were randomly allocated into six groups as follows:

Control Group (n=15) Final irrigation was performed using sterile saline

Group 1 - Apple Cider Vinegar (n=15) Irrigation was performed using 5% apple cider vinegar, followed by final irrigation with sterile saline. Apple Cider Vinegar has demonstrated antimicrobial efficacy due to its acetic acid content Group 2 - Diode Laser (n=15) A 940nm diode laser was used for canal disinfection in the presence of saline. Diode lasers have been shown to penetrate dentinal tubules and reduce anaerobic bacterial load effectively Group 3 - Gymnema Sylvestre (n=15) Disinfection was carried out using the Gymnema Sylvestre mother tincture Q 1000 CH solution in the presence of saline. Gymnema sylvestre exhibits documented antimicrobial and anit-infalamatory properties

Group 4 - Diode Laser + Apple Cider Vinegar (n=15) Disinfection was performed using a 940 nm diode laser in the presence of 5% apple cider vinegar followed by saline irrigation

Group 5 - Diode laser + Gymenam Sylvestre (n=15) Disinfection was performed using a 940 nm diode laser in the presence of Gynema Sylvestre mother tincture followed by saline irrigation.

Post-disinfection Sampling After completion of cleaning and shaping and final disinfection protocols, post-treatment microbial samples were collected using sterile paper points and transported in T.E buffer for PCR analysis to assess bacterial reduction.

Follow-up and Outcome Assessment Patients were recalled at 7, 15, 30, 45, 60 days for follow-up Clinical outcome was measured using RVG and PAI was calculated Post-operative pain was assessed using a VAS, a validated toll for pain assessment in endodontics studies Microbiological analysis using traditional polymerase chain reaction (PCR)

03

Conditions studied

  • Diabete Type 2

Keywords

  • Endodontics
  • Diode laser
  • Apple cider vinegar
  • Gymnema sylvestre
04

Who can participate

Ages eligible
25 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Using radiographs, intraoral periapical radiographs (RVG) primary endodontic infection will be selected.
  • Multirooted teeth , root with periapical lesion will be selected
  • Type 2 diabetics between the ages of 25 years and 60 years will be chosen; both male and female patients
  • A fasting blood sugar level of 126 mg/dl and a random blood sugar level of less than 200 mg/dl
  • (glycated haemoglobin) ≥ 6.5%

Exclusion criteria

Exclusion Criteria:

  • Patients with systemic conditions other than type 2 diabetes
  • Women who are pregnant
  • Those patients that have used antibiotics within the previous three months,
  • Those patients that have teeth with developmental defects, calcified canals,
  • Teeth that cannot be isolated with rubber dams,
  • Tortuous canals
  • Roots that are fractured
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Saline

    Saline is used in the ideal conditions

    Other: 940 nm diode laser · Other: apple cider vinegar · Other: Gymnema Sylvestre · Other: Saline (NaCl) · Other: Diode laser and Gymnema Sylvestre · Other: Diode laser and apple cider vinegar

  • Experimental
    940 nm diode laser

    it is used for disinfecting the canal

    Other: 940 nm diode laser · Other: apple cider vinegar · Other: Gymnema Sylvestre · Other: Saline (NaCl) · Other: Diode laser and Gymnema Sylvestre · Other: Diode laser and apple cider vinegar

  • Experimental
    Apple cider vinegar

    It is used as irrigating agent

    Other: 940 nm diode laser · Other: apple cider vinegar · Other: Gymnema Sylvestre · Other: Saline (NaCl) · Other: Diode laser and Gymnema Sylvestre · Other: Diode laser and apple cider vinegar

  • Experimental
    Gymnema sylvestre

    It is used as irrigating agent

    Other: 940 nm diode laser · Other: apple cider vinegar · Other: Gymnema Sylvestre · Other: Saline (NaCl) · Other: Diode laser and Gymnema Sylvestre · Other: Diode laser and apple cider vinegar

  • Experimental
    940 diode laser and Apple cider vinegar

    For disinfecting the canal

    Other: 940 nm diode laser · Other: apple cider vinegar · Other: Gymnema Sylvestre · Other: Saline (NaCl) · Other: Diode laser and Gymnema Sylvestre · Other: Diode laser and apple cider vinegar

  • Experimental
    940 diode laser and Gymnema sylvestre

    For disinfecting the canal

    Other: 940 nm diode laser · Other: apple cider vinegar · Other: Gymnema Sylvestre · Other: Saline (NaCl) · Other: Diode laser and Gymnema Sylvestre · Other: Diode laser and apple cider vinegar

Interventions

  • Other940 nm diode laser

    laser for irrigation

    Also known as: diode laser

  • Otherapple cider vinegar

    5% apple cider vinegar

  • OtherGymnema Sylvestre

    antidiabetic agent

    Also known as: gudmar

  • OtherSaline (NaCl)

    saline is used as ideal irrigant

    Also known as: saline

  • OtherDiode laser and Gymnema Sylvestre

    This is the combination disinfection

    Also known as: combination therapy

  • OtherDiode laser and apple cider vinegar

    combination therapy used will enhance the disinfection

06

What researchers measure

Primary outcomes

  1. Visual Analog Scale (VAS)

    A Visual Analog Scale is a validated, subjective, 1-dimensional tool used to measure intensity, most commonly pain. It consists of a 10-cm (100-mm) horizontal or vertical line, with endpoints anchored by extremes, such as "no pain" and "worst imaginable pain," with patients marking their level

    Time frame: 6 months

  2. Detection of peptostreptococcus species after the use of intervention

    Absence of peptostreptococcus species on PCR signifies disinfection of canal presence of peptostreptococcus species on PCR signifies irrigating agent is not effective

    Time frame: one year

07

Study locations

1 of 1 sites recruiting
  • Dr Lakshmi Pandey
    Noida, Uttar Pradesh 201310, India
    Recruiting
08

References and documents

Publications

  • Jambagi N, Kore P, Dhaded NS, Patil SA, Shankar M. Comparison of Antimicrobial Efficacy of Diode Laser, Ultrasonic Activated and Conventional Irrigation with 2.5% NaOCl during RCT: An Interventional Study. J Contemp Dent Pract. 2021 Jun 1;22(6):669-673. PubMed 34393125 ↗
  • Sonarkar SS, Singh S, Podar R, Kulkarni G, Purba R. An in vivo comparison of the antibacterial efficacy of photoactivated disinfection, diode laser, and 5% sodium hypochlorite in root canal disinfection. J Conserv Dent. 2018 Mar-Apr;21(2):205-209. doi: 10.4103/JCD.JCD_227_17. PubMed 29674826 ↗
  • Mota AC, de Castro RD, de Araujo Oliveira J, de Oliveira Lima E. Antifungal Activity of Apple Cider Vinegar on Candida Species Involved in Denture Stomatitis. J Prosthodont. 2015 Jun;24(4):296-302. doi: 10.1111/jopr.12207. Epub 2014 Sep 14. PubMed 25219289 ↗
  • Mirzaei M, Rahmaninan M, Mirzaei M, Nadjarzadeh A, Dehghani Tafti AA. Epidemiology of diabetes mellitus, pre-diabetes, undiagnosed and uncontrolled diabetes in Central Iran: results from Yazd health study. BMC Public Health. 2020 Feb 3;20(1):166. doi: 10.1186/s12889-020-8267-y. PubMed 32013917 ↗
  • Korona-Glowniak I, Piatek D, Fornal E, Lukowiak A, Gerasymchuk Y, Kedziora A, Bugla-Ploskonska G, Grywalska E, Bachanek T, Malm A. Patterns of Oral Microbiota in Patients with Apical Periodontitis. J Clin Med. 2021 Jun 19;10(12):2707. doi: 10.3390/jcm10122707. PubMed 34205290 ↗
  • Farcas-Berechet CM, Berechet EM, Craitoiu S, Alexandru DO, Gheorghe AG, Gheorghita LM, Diaconu OA, Tuculina MJ, Moraru AI, Iacov-Craitoiu MM. Statistical Study of Dental Changes in Patients Diagnosed with Diabetes Mellitus. Curr Health Sci J. 2019 Apr-Jun;45(2):190-197. doi: 10.12865/CHSJ.45.02.10. Epub 2019 Jun 30. PubMed 31624647 ↗
  • Owlia F, Zarezadeh F, Jambarsang S, Kazemipoor M. Comparison of the Response to Pulpal Sensibility Tests in Well-Controlled and Uncontrolled Type II Diabetes Mellitus Patients: A Cross-Sectional Study. Int J Dent. 2022 Sep 13;2022:6197070. doi: 10.1155/2022/6197070. eCollection 2022. PubMed 36148044 ↗
  • Nair RR, Nayak M, Prasada LK, Nair AV, Soman D, Krishnan RH. PCR-based detection of three anaerobic bacteria associated with endodontic-periodontic lesions in type-2 diabetic and nondiabetic subjects. J Conserv Dent. 2019 Sep-Oct;22(5):430-435. doi: 10.4103/JCD.JCD_326_19. Epub 2020 Aug 4. PubMed 33082657 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — PROTOCOL STRATERGIES, STATISTICAL ANALYSIS

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: one year

Access criteria: anyone with the link

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2026 to primary completion in Aug 2026, 3 months.

Of 2,078 non-industry interventional studies with no phase under Diabetes Mellitus, Type 2, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's 3 months is below that.

Counting every sponsor, half of 2,255 studies reached it within 21 months; a quarter within 10 and three quarters within 39.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 19, 2026: primary completion Dec 2026 → Aug 2026 and completion May 2027 → Dec 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 1, 2026
First posted
Apr 24, 2026
StartActual
May 1, 2026
Primary completionActual
Aug 31, 2026was Dec 2026
CompletionEst.
Dec 31, 2026was May 2027
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Dec 31, 2026→Aug 31, 2026 (actual)
Nov 19, 2026
Study completion
May 1, 2027→Dec 31, 2026
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    Primary completion Dec 31, 2026→Aug 31, 2026 (now actual)
    Study completion May 1, 2027→Dec 31, 2026
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07549373
Lead sponsor
Sharda University
Responsible party
Dr Lakshmi Pandey (Associate professor, Sharda University) — Principal investigator
First posted
Apr 24, 2026
Start date
May 1, 2026
Primary completion
Aug 31, 2026
Completion
Dec 31, 2026 (estimated)
Last update
Nov 19, 2026

Study contacts

Lakshmi Pandey, MDS
Contact
drlakshmipandey024@gmail.com
+917349052235
Dr Ekta Choudhary, MDS
study director · School of Dental Sciences , Sharda University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion